Orchid Fertility Eliminates Embryo Biopsy Risks with Advanced Genetic Testing

The technique makes genetic tests more accessible to couples that are subjected to IVF

The fertility of the Dubai orchid is at the forefront of reproductive technology with an innovative response to one of the greatest challenges in assisted reproduction: that is, the selection of healthier embryos while eliminating the risks associated with traditional test methods. With the introduction of non -invasive genetic tests of preimplantation (NIPGT), the fertility of orchids is transforming the experience of IVF to increase the probability of a successful pregnancy and minimize stress in embryos.

Defective embryo genetics is among the main causes of spontaneous abortion, IVF fault and birth defects. Technological advances now offer new hope, thought. The genetic preimplantation (PGT) tests allow doctors to detect embryos before implantation, so only the healthiest are selected. It involves a biopsy: a process that extracts embryo cells to test what inevitably puts a small stress.

“Through the use of non-invasive pre-implantation genetic tests, we can analyze a genetic embryo composition without the need for biopsy,” he said Dr. Dimitrios Kafetzis, Medical Director of Orchid Fertility Dubai. “This technology avoids any risk, which allows us to provide the patient’s tranquility and still provide information about their embryos.”

The NIGGT method is based on DNA analysis that the embryo naturally releases in the culture environment as it grows. This non -invasive approach allows specialists to detect chromosomal abnormalities without compromising the structural integrity of the embryo.

This technology is especially useful for women about 35 years old, and those with multiple FIV cycles failed due to an inexplicable implementation failure. The fertility of the orchid sacrifices a complete set of genetic detection services, such as PGT-A for chromosomal anomalies such as Down, PGT-M syndrome for monogenic conditions such as the anemia of falciform cells and cystic fibrosis, PGT-SR for inhomales transporters, and and the spectacities and sions and sions Sroslocaciones, and the sesrants.

“Selecting the most appropriate embryo for implantation has a long leg an important aspect or an in vitro fertilization; and we are always looking for a less invasive alternative to PGTA.”

NIPT is not a substitute or PGTA, but a detection tool to select the best embryos. Together with the latest generation embryochopope. Orchid fertility is making the best reproductive medicine in their class accessible to families and, therefore, gives them the greatest possibility of having a healthy baby.

About orchid fertility
The fertility of orchids, part of Waha Health and located in the heart of the city of Dubai Healthcare, establishes the reference point for high quality fertility care in the United Arab Emirates. The clinic is dedicated to providing evidence based on fertility that meet international standards, sacrificing couples the best possible opportunity to make their dream of having a healthy baby.

With a holistic approach to fertility, the fertility of orchid emphasizes the importance of balancing the emotional, physical and mental well -being of couples, recognizing that successful fertility treatment requires more than only one medical intervention. The personalized attention of the clinic ensures that the individual needs of each couple are with, including diet considerations, stress management and lifestyle improvements.

Orchid fertility undertakes to improve the quality of life of couples seeking fertility assistance, with an approach to achieving healthy pregnancies and promoting the development of strong and healthy families. The clinic adheres to rigorous international quality standards, which combines first level experience with the latest advances in technology, all while providing compassionate and patient focused.

For more information: www.orchid- fertility.com